ArticleEuropean urology2015

Re: Phase 2 Trial of Neoadjuvant Axitinib in Patients with Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma.

Francesco Greco et al.PubMed ↗Publisher ↗

No numbers read from the abstract.